Therapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma

Table 1 Patient data before initiation of radiotherapy (n = 94)

Data	n (%)
Age (yr)
< 60	78(83.0)
≥ 60	16(17.0)
Gender
Male	84(89.4)
Female	10(10.6)
Alpha-fetoprotein
> 400 ng/mL	64 (68.1)
≤ 400 ng/mL	30(31.9)
Child-Pugh classification for cirrhosis of liver
Class A	43(45.7)
Class B	51(54.3)
Karnofsky performance score
> 70	90(95.7)
< 70	4(4.3)
Okuda stage
I	63(67.0)
II	31(33.0)
Tumor size (cm)
< 5	17(18.1)
5-10	40(42.6)
> 10	37(39.3)
Tumor type
Massive	66(70.2)
Multinodular	28(29.8)
PVT
Yes	12(12.8)
No	82(87.2)
Albuminemia
< 3 g/dL	15(16.0)
> 3 g/dL	79(84.0)
Bilirubinemia
< 3 mg/dL	29(30.9)
> 3 mg/dL	65(69.1)
Chronic hepatitis in serum virology
Type B	90(95.7)
Type C	4(4.3)
Radiation dose
60 Gy	34(36.2)
56 Gy	34(36.2)
48 Gy	26(27.6)
TACE
1 fraction	59(62.8)
> 1 fraction	35(37.2)